Shannon earned a bachelor’s degree in chemistry in 2003 from Ithaca College, and a Ph.D. in biochemistry with a focus on systems biology in 2009 from University of California, San Diego. Prior to joining MAPS Public Benefit Corporation (MAPS PBC), Shannon worked in oncology drug development as a pre-clinical Research Scientist at Merrimack Pharmaceuticals and was a key contributor to the IND approval of MM-151, an anti-EGFR oligoclonal antibody therapeutic. Shannon also served as a Clinical Project Manager and Biomarker Strategy Lead at Epic Sciences to evaluate the prognostic and predictive value of circulating tumor cells (CTCs) as companion diagnostics for pharmaceutical partner-sponsored drug trials. Most recently, Shannon worked as a Staff Clinical Research Scientist/Clinical Program Lead at Leica Biosystems, where she led pre- and post-market clinical studies for oncology tissue diagnostics. In addition to her drug and diagnostic development experience, Shannon is also an experienced mindful movement teacher, Transformational Nutrition Coach, and facilitator of Reiki Energy Healing and Sound Healing.
At MAPS PBC, Shannon is currently serving as a Clinical Program Manager, focusing on overseeing the MDMA-assisted therapy trials for the Innovation Program and VA studies. Her passion lies at the intersection of science and spirituality, and she strongly believes in the power of psychedelic medicine for healing and expansion of human consciousness. In her free time, Shannon is a Psychedelic Peer Support Volunteer with Fireside Project, and loves creating/playing music, dance, being in nature, meditation, cooking, and having spirited conversations about life, healing, psychedelics, and consciousness over a cup of tea or cacao.